Propranolol May Reduce Overall Stroke Risk in Women With Migraine

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

FRIDAY, Jan. 31, 2025 -- Propranolol is associated with a reduced risk for overall stroke among women with migraine, with a more pronounced protective effect for ischemic stroke, according to a study presented at the annual American Stroke Association International Stroke Conference, held from Feb. 5 to 7 in Los Angeles.

Mulubrhan Mogos, Ph.D., from the Vanderbilt University School of Nursing in Nashville, Tennessee, and colleagues conducted a retrospective case-control study to examine the role of propranolol in reducing stroke risk among patients with migraine. A total of 378 stroke cases (patients with a primary diagnosis of stroke after the first onset of migraine) and 15,209 controls (patients with no stroke diagnosis after the first onset of migraine) were identified from the Synthetic Derivative (SD) at Vanderbilt University Medical Center, while 267 cases and 6,579 controls were included from the All of Us database.

The researchers found that in female patients with migraine, propranolol was significantly associated with a reduced risk for overall stroke (odds ratios, 0.52 in SD and 0.39 in All of Us), but this association was not seen in male patients. A more pronounced protective effect was seen for ischemic stroke and in women with migraine without aura. Cumulative incidence analyses showed lower stroke rates at multiple time points.

"Many women suffer from migraines, and it's important to note that propranolol may be beneficial for these women, particularly those who experience migraine without aura," Mogos said in a statement. "This is an important discovery for those dealing with migraines."

Press Release

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-02-01 12:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords